AAPL
55
2
C
85
3
PSA
37
2
HSY
50
5
NEM
69
-2
D
45
4
NEE
52
2
A
46
2
ETN
61
2
MSI
47
-2
HBAN
82
2
PFE
38
2
PEG
50
4
COST
53
5
EL
59
-2
KMB
33
2
HOG
38
2
PHM
43
2
CRM
59
-11
MCD
46
4
AAPL
55
2
C
85
3
PSA
37
2
HSY
50
5
NEM
69
-2
D
45
4
NEE
52
2
A
46
2
ETN
61
2
MSI
47
-2
HBAN
82
2
PFE
38
2
PEG
50
4
COST
53
5
EL
59
-2
KMB
33
2
HOG
38
2
PHM
43
2
CRM
59
-11
MCD
46
4
Financhill
Back

Keros Therapeutics, Inc. Vs. Travere Therapeutics, Inc. Industry Stock Comparison

Buy
60

KROS
Keros Therapeutics, Inc.

Last Price:
$21.34
Seasonality Move:
4.91%
Buy
80

TVTX
Travere Therapeutics, Inc.

Last Price:
$40.3200
Seasonality Move:
33.23%
Buy
60
Keros Therapeutics, Inc. (KROS) is a Buy

Is Keros Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Keros Therapeutics, Inc. [KROS] share price is $21.36. The Score for KROS is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • KROS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
80
Travere Therapeutics, Inc. (TVTX) is a Buy

Is Travere Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Travere Therapeutics, Inc. [TVTX] share price is $40.2800. The Score for TVTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

KROS Stock Price Chart

What is Keros Therapeutics, Inc.'s stock price today?

  • The Keros Therapeutics, Inc. share price today is $21.36
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KROS is experiencing slight buying pressure.

TVTX Stock Price Chart

What is Travere Therapeutics, Inc.'s stock price today?

  • The Travere Therapeutics, Inc. share price today is $40.2800
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight buying pressure.

KROS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.04 Buy
Relative Strength Index (14 RSI): 64.89 Buy
Chaikin Money Flow: 103386 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.63 - 21.61) Buy
Bollinger Bands (100): (14.24 - 18.68) Buy

TVTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.67 Buy
Relative Strength Index (14 RSI): 69.35 Buy
Chaikin Money Flow: 1508490 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.0318 - 36.4718) Buy
Bollinger Bands (100): (20.7309 - 34.2909) Buy

KROS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.01 Buy
20-day SMA: 20.25 Buy
50-day SMA: 17.67 Buy
200-day SMA: 14.9 Buy
8-day EMA: 21.04 Buy
20-day EMA: 20.22 Buy
50-day EMA: 18.48 Buy
200-day EMA: 18.75 Buy

TVTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.7 Buy
20-day SMA: 35.23 Buy
50-day SMA: 33.43 Buy
200-day SMA: 22.2 Buy
8-day EMA: 28.52 Buy
20-day EMA: 16.32 Buy
50-day EMA: 7.67 Buy
200-day EMA: 2.09 Buy

Keros Therapeutics, Inc. Earnings Growth & KROS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.62 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.45 per share, and a decrease next year of $5.27 per share.

Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.

Keros Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Travere Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):